Skip to main content

Table 2 Univariate analysis for overall survival of patients with nasopharyngeal carcinoma

From: Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma

Kaplan-Meier Survival Rate
     Censored  
   Total Dead N % P-value
  Overall 50 16 34 68.0  
T Negative 7 3 4 57.1 0.543
  Positive 43 13 30 69.8  
B Negative 9 4 5 55.6 0.253
  Positive 41 12 29 70.7  
FDC Negative 20 8 12 60.0 0.286
  Positive 30 8 22 73.3  
CD80* Negative 40 16 24 60.0 0.025
  Positive 10 0 10 100.0  
CD86* Negative 40 16 24 60.0 0.025
  Positive 10 0 10 100.0  
CD80/86* Negative 39 16 23 59.0 0.017
  Positive 11 0 11 100.0  
HLA1DR Negative 15 7 8 53.3 0.167
  Positive 35 9 26 74.3  
S100 Negative 20 7 13 65.0 0.654
  Positive 30 9 21 70.0  
  1. P-value by Log-rank test
  2. Follow-up time: from diagnosis date till death/2-15-2007